Form 4 for DH Definitive Healthcare Corp.
Accepted 2024-07-08 00:00:00 ET · period of report 2024-07-04 · accession 0001415889-24-019340 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-08 | 2024-07-04 | DH | Coop Kevin | CEO, Dir | A - Grant | $0.00 | +186.2K | 1.36M | +16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-07-04 | A | A | 186,192 | $0.00 | 1,356,239 | D | — | — | (F1) Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001 (the "Class A Common Stock"), with 25% of the RSUs vesting on July 1, 2025, followed by vesting of 6.25% every three months thereafter over the subsequent three years, subject to the Reporting Person's continued service with the Issuer through each such vesting date. |